Rtw Investments Raised Oxford Immunotec Global Plc (OXFD) Position; 0 Analysts Covering Alphatec Holdings (ATEC)

June 20, 2017 - By Hazel Jackson

Rtw Investments Llc increased Oxford Immunotec Global Plc (OXFD) stake by 130.3% reported in 2016Q4 SEC filing. Rtw Investments Llc acquired 307,387 shares as Oxford Immunotec Global Plc (OXFD)’s stock rose 4.03%. The Rtw Investments Llc holds 543,287 shares with $8.12M value, up from 235,900 last quarter. Oxford Immunotec Global Plc now has $340.91 million valuation. The stock declined 1.46% or $0.22 reaching $14.83 on the news. About 51,948 shares traded. Oxford Immunotec Global PLC (NASDAQ:OXFD) has risen 54.26% since June 20, 2016 and is uptrending. It has outperformed by 37.56% the S&P500.

Among 2 analysts covering Alphatec Holdings Inc. (NASDAQ:ATEC), 0 have Buy rating, 1 Sell and 1 Hold. Therefore 0 are positive. Alphatec Holdings Inc. had 3 analyst reports since August 5, 2015 according to SRatingsIntel. The firm has “Hold” rating given on Friday, August 7 by Zacks. The firm has “Underperform” rating by Northland Capital given on Monday, March 14. On Wednesday, August 5 the stock rating was downgraded by Canaccord Genuity to “Hold”. See Alphatec Holdings Inc (NASDAQ:ATEC) latest ratings:

Investors sentiment decreased to 1.54 in Q4 2016. Its down 1.61, from 3.15 in 2016Q3. It is negative, as 1 investors sold OXFD shares while 23 reduced holdings. 9 funds opened positions while 28 raised stakes. 18.05 million shares or 49.32% less from 35.61 million shares in 2016Q3 were reported. Cam Group Holdings A S holds 160,000 shares. Goldman Sachs Gp reported 12,974 shares. New York State Common Retirement Fund holds 0% of its portfolio in Oxford Immunotec Global PLC (NASDAQ:OXFD) for 26,887 shares. Citigroup holds 0% in Oxford Immunotec Global PLC (NASDAQ:OXFD) or 33,463 shares. Grandeur Peak Global Limited Company reported 649,403 shares stake. 3,821 are owned by Bank Of America Corp De. Birchview Capital Lp reported 67,303 shares. Endurant Cap Mgmt LP reported 16,056 shares or 0.1% of all its holdings. Legal General Public Ltd Liability Corporation holds 0% in Oxford Immunotec Global PLC (NASDAQ:OXFD) or 6,440 shares. Moreover, Blackrock Fund Advisors has 0% invested in Oxford Immunotec Global PLC (NASDAQ:OXFD). Schwab Charles Investment owns 40,500 shares. Moreover, Kornitzer Capital Ks has 0.02% invested in Oxford Immunotec Global PLC (NASDAQ:OXFD). First Light Asset Mngmt Limited Liability Co accumulated 747,639 shares or 4.91% of the stock. Neuberger Berman Group Inc Limited Liability Co holds 0% in Oxford Immunotec Global PLC (NASDAQ:OXFD) or 55,100 shares. Bancshares Of Mellon invested 0% of its portfolio in Oxford Immunotec Global PLC (NASDAQ:OXFD).

Since February 6, 2017, it had 0 buys, and 9 selling transactions for $1.80 million activity. SANDBERG RICHARD A sold $46,420 worth of stock. 30,000 shares were sold by Wrighton-Smith Peter, worth $463,005 on Monday, April 3. On Thursday, June 15 Keiley Elizabeth M sold $61,305 worth of Oxford Immunotec Global PLC (NASDAQ:OXFD) or 4,085 shares. Edwardson Peter also sold $88,382 worth of Oxford Immunotec Global PLC (NASDAQ:OXFD) on Friday, February 24. Schroeder Jeff R. had sold 40,000 shares worth $565,659 on Monday, May 8.

Rtw Investments Llc decreased Atara Biotherapeutics Inc (NASDAQ:ATRA) stake by 85,489 shares to 372,624 valued at $5.29 million in 2016Q4. It also reduced Global Blood Therapeutics In stake by 69,751 shares and now owns 25,963 shares. La Jolla Pharmaceutical Co (NASDAQ:LJPC) was reduced too.

Alphatec Holdings, Inc. is a medical technology company. The company has market cap of $20.98 million. The Firm through its subsidiary, Alphatec Spine, Inc. and its subsidiaries, designs, develops, makes and markets products for the surgical treatment of spine disorders. It currently has negative earnings. The Company’s product portfolio and pipeline addresses the cervical, thoracolumbar and intervertebral regions of the spine and covers a range of spinal disorders and surgical procedures.

It is down 6.76% since June 20, 2016 and is downtrending. It has underperformed by 23.46% the S&P500.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: